Insight as a social identity process in the evolution of psychosocial functioning in the early phase of psychosis. by Klaas, H.S. et al.
Insight as a social identity process in the evolution
of psychosocial functioning in the early phase
of psychosis
H. S. Klaas1*, A. Clémence2, R. Marion-Veyron3, J.-P. Antonietti2, L. Alameda3, P. Golay3 and
P. Conus3
1Swiss National Centre of Competence in Research LIVES, Life Course and Inequality Research Centre (LINES), Faculty of Social and Political
Sciences, University of Lausanne, Switzerland
2Psychology Institute, Faculty of Social and Political Sciences, University of Lausanne, Lausanne, Switzerland
3Treatment and Early Intervention in Psychosis Program (TIPP), Service of General Psychiatry, Département de Psychiatrie Centre Hospitalier
Universitaire Vaudois (CHUV), Université de Lausanne, Clinique de Cery, 1008 Prilly, Switzerland
Background. Awareness of illness (insight) has been found to have contradictory effects for different functional out-
comes after the early course of psychosis. Whereas it is related to psychotic symptom reduction and medication adher-
ence, it is also associated with increased depressive symptoms. In this line, the speciﬁc effects of insight on the evolution
of functioning over time have not been identiﬁed, and social indicators, such as socio-occupational functioning have
barely been considered. Drawing from social identity theory we investigated the impact of insight on the development
of psychosocial outcomes and the interactions of these variables over time.
Method. The participants, 240 patients in early phase of psychosis from the Treatment and Early Intervention in
Psychosis Program (TIPP) of the University Hospital of Lausanne, Switzerland, were assessed at eight time points
over 3 years. Cross-lagged panel analyses and multilevel analyses were conducted on socio-occupational and general
functioning [Social and Occupational Functioning Assessment Scale (SOFAS) and Global Assessment of Functioning
(GAF)] with insight, time and depressive symptoms as independent variables.
Results. Results from multilevel analyses point to an overall positive impact of insight on psychosocial functioning,
which increases over time. Yet the cross-lagged panel analysis did not reveal a systematic positive and causal effect
of insight on SOFAS and GAF scores. Depressive symptoms seem only to be relevant in the beginning of the treatment
process.
Conclusions. Our results point to a complex process in which the positive impact of insight on psychosocial functioning
increases over time, even when considering depressive symptoms. Future studies and treatment approaches should con-
sider the procedural aspect of insight.
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Introduction
When comparing ﬁrst-episode-psychosis patients to
those suffering from other mental illnesses, the propor-
tion of people showing no insight into their illness is
especially high (Fennig et al. 1996; Conus et al. 2007;
Saeedi et al. 2007). Lack of insight can be deﬁned as
an unawareness of the deﬁcits, the consequences of
the disorder and the need for treatment (Amador
et al. 1991). Based on the literature, the impact of
insight on different functional outcomes seems to be
contradictory. On the one hand, awareness of illness
is linked to treatment compliance, such as medication
adherence and positive and negative symptom im-
provement (Mintz et al. 2004; McEvoy et al. 2006;
Buchy et al. 2010). On the other hand, insight has
been associated with increased depressive symptoms
(Crumlish et al. 2005; McEvoy et al. 2006; Buchy et al.
2010; Cotton et al. 2012), especially at the beginning
of the treatment process (Saeedi et al. 2007).
Furthermore, insight into illness has been related to a
decrease in quality of life (Kravetz et al. 2000) and self-
esteem (Lysaker et al. 2007). Previous research has not
yet disentangled these conﬂicting effects on function-
ing due to two main pitfalls: ﬁrst, the covariation be-
tween insight and functional outcomes has not been
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thoroughly studied longitudinally, and second, a psy-
chosocial perspective on the interaction between in-
sight and remission from early psychosis has barely
been considered in papers published so far.
Studies investigating the interaction between insight
and the process of remission from early psychosis over
time assessed patients either retrospectively (Cotton
et al. 2009) or prospectively over a relatively short time-
frame (Mintz et al. 2004; Parellada et al. 2009; Buchy
et al. 2010; Capdevielle et al. 2013; O’Connor et al.
2013). Few studies followed patients up to 3 or 4
years either retrospectively (Gómez-de-Regil et al.
2010) or prospectively (Crumlish et al. 2005; Saeedi
et al. 2007). Yet these studies assessed information
only once a year and did not allow a detailed explor-
ation of the evolution of functioning.
Furthermore, predominant models explaining a lack
of insight consider the individual without taking the
social context into account. While some explanatory
models for lack of insight suggest a central role for in-
ternal mechanisms resulting directly from psychosis or
resulting from cognitive deﬁcits linked to the disorder
(e.g. Henriksen & Parnas, 2014), others conceptualize it
as a motivational defense mechanism (Thompson et al.
2001; for an overview, see Cooke et al. 2005).
When facing a ﬁrst episode of psychosis, patients do
not only need to cope with the symptoms of the dis-
order, but also with the emergence of a new identity
and the possible loss of old ones; therefore, taking
the perspective of social identity theory (Tajfel &
Turner, 1986; Ellemers et al. 2002) – and its applications
to health events such as coping with stroke (Haslam
et al. 2008) or depression (Cruwys et al. 2013) – seems
highly relevant when exploring this domain. Indeed,
in the early phase of psychosis patients have to inte-
grate a new self-deﬁnition and must do so within a so-
cial context in which schizophrenia is stigmatized
(Lauber et al. 2000; Thornicroft et al. 2009); an acknowl-
edgement of the ‘schizophrenic’ identity therefore
threatens their self-esteem. The phenomenon of social
categorization implies that the patient will be per-
ceived and treated differently than before by others,
which may explain why he or she is likely to be torn
between acknowledgment and refusal of the schizo-
phrenic identity. The development of functioning is
therefore not limited to the remission of clinical symp-
toms, and should rather, as recently suggested, be seen
‘primarily (as) a process of transforming identity’
(Williams, 2008, p. 246; see also Haslam et al. 2009).
We argue that this identity transformation, which is
central for the evolution of functional outcomes, can
best be observed when considering the evolution of so-
cial and occupational functioning. Surprisingly, even if
the social functioning in everyday life represents a very
important domain of remission from schizophrenia as
it is an important dimension of social integration
(Rinaldi et al. 2010), longitudinal research on insight
and early psychosis has so far focused predominantly
on its link to clinical symptoms (Buchy et al. 2010;
O’Connor et al. 2013). When considering research in-
vestigating established schizophrenia, there is some
cross-sectional (Karow et al. 2008; Giugiario et al.
2012) and longitudinal evidence (Lincoln et al. 2007;
Mohamed et al. 2009; Parellada et al. 2009) that an im-
provement in insight is related to an improvement of
social or occupational functioning. One recent study
found an increasingly positive association of insight
and social functioning over the period of 1 year in in-
voluntarily admitted patients with schizophrenia
(van Baars et al. 2013). These ﬁndings indicate a posi-
tive correlation between insight and social integration,
but they do not provide sufﬁcient information regard-
ing both the evolution and the causal direction of this
relation in the early phase of psychosis.
The present study tries to address the mentioned re-
search gaps in the context of the prospective 3-year
follow-up of early psychosis patients with two meas-
urement points per year. Based on social identity the-
ory, we hypothesized that the interactions of insight
and psychosocial functioning over time would depend
on the process in which a person acknowledges or not
the mental disorder and therefore the social identity of
a ‘schizophrenic person’ (Williams, 2008). Following
this reasoning, a recognition of the illness (insight)
and hence the perception of the negative social label
attached to it should lead in the beginning of the evo-
lution of functioning to an increase in depressive
symptoms. In order to recover or maintain a positive
self-esteem and positive relationships with others
(Tajfel & Turner, 1986; Baumeister & Leary, 1995),
the patient might then be led to resist the stigmatized
self-deﬁnition (no insight), which should be associated
with decreased depressive symptoms. Maintaining de-
nial, however, is often complicated when facing the
consequences of the illness. Furthermore, over time,
recognizing the illness could also have positive effects,
considering that the relationship with caregivers often
depends on the patients acknowledging their difﬁcul-
ties, which in turn fosters good social interactions with-
in the treatment context, promotes a better self-esteem
and enhances the protection against stigma and nega-
tive stereotyping (Crocker & Major, 1989; Camp et al.
2002; Crabtree et al. 2010).
With this in mind, the aims of this study were to ex-
plore the pattern of interactions between insight, both
self-esteem and depressive symptoms, and social func-
tioning over the 3 ﬁrst years of treatment in a sample of
early phase of psychosis patients in the frame of a spe-
cialized early intervention program. Hypotheses were
that
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(1) The level of insight would be correlated with the
level of functional outcome, and this positive cor-
relation would increase with time.
(2) The correlation of depressive symptoms with in-
sight would decrease while the correlation of self-
esteem and insight would increase with time.
(3) Change of insight between two time points would
cause a corresponding change of functional out-
come. That is, insight at time X should have a posi-
tive effect on functional outcome at time X + 1.
Method
Procedure and participants
Treatment and early Intervention in Psychosis
Program (TIPP), a specialized early psychosis pro-
gram, was launched in 2004 at the Department of
Psychiatry CHUV, in Lausanne, Switzerland, and the
concept and study methods have been described else-
where in details (Baumann et al. 2013). Entry criteria
to the program are: (i) age between 18 and 35 years;
(ii) residence in the catchment area; (iii) meeting
threshold criteria for psychosis, as deﬁned by the
‘Psychosis threshold’ subscale of the Comprehensive
Assessment of At Risk Mental States (CAARMS;
Yung et al. 2005) scale. Patients are referred to other
treatment programs if they have been taking anti-
psychotic medication for more than a total of 6 months,
have psychosis related to intoxication or organic brain
disease, or have an intelligence quotient below 70.
A specially designed questionnaire (the TIPP Initial
Assessment Tool: TIAT) is completed for all patients
enrolled in the program by case managers who, in
the frame of a caseload of 30 patients, have up to 100
contacts with patients during the 3 years of treatment.
It allows assessment of demographic characteristics,
past medical history, exposure to life events as well
as symptoms and functioning. It is completed on the
basis of information gathered with patients and their
family over the ﬁrst few weeks of treatment and can be
updated during follow-up if new information emerges.
Follow-up assessments exploring various aspects of
treatment and co-morbidities aswell as evolutionof psy-
chopathology and functional level are conducted by
trained research psychologists for scale based assess-
ment (with assessment of inter-rater reliability) and by
case managers (for objective measures such as employ-
ment and living conditions for example) after 2, 6, 12,
18, 24, 30 and 36months in treatment. In particular, sub-
stance abuse diagnosis was assessed at each time point
and rated on the basis of DSM-IV criteria (APA, 2000).
The Research and Ethics Committee of the Faculty of
Biology and Medicine of Lausanne University granted
access to TIPP clinical data for research purposes.
The present study was based on the 240 patients
who had been enrolled in the program and who had
been in treatment for 36 months at the time of the
study. They were between 17 and 37 years old
(mean = 24.0, S.D. = 4.8) when entering the program,
and lived in the urban area of Lausanne, one of the big-
gest cities in Switzerland (about 300000 inhabitants).
The city is economically well developed, especially in
the ﬁelds of health, research, education, social services
and culture, and also banking, insurance and tourism.
More than 40% of people are immigrants, most of them
coming from European countries. Compared to the
population of this generation in Lausanne, men (n =
166, 69% of the sample) and immigrants (n = 155,
65%) were overrepresented. Regarding the family situ-
ation, 83% of the patients were single, and 42% lived
with their parents. The level of education, measured
by years of school, corresponded to the achievement
of the compulsory school, the lowest level in
Switzerland (mean = 9.5, S.D. = 1.3), and 66% had no
professional or educational activity when they entered
the program.
Diagnostic assessment
In the TIPP program, diagnosis is the result of an ex-
pert consensus and is based on the following elements:
(1) Diagnosis reported by a treating psychiatrist in all
medical documents and at the end of any hospitaliza-
tion; (2) Longitudinal assessment by clinical case man-
agers over the 3 years of treatment. The consensus
diagnosis procedure is realized by a senior psychiatrist
and the senior psychologist who is in charge of scale-
based assessment over the treatment period. They
both review the entire ﬁle once after 18 months and
again after 36 months or at the end of treatment and
conduct a diagnostic process based on DSM-IV criteria
(APA, 1994) discussing any unclear issue with the clin-
ical case manager. In this paper, only the ﬁnal diagno-
sis, deﬁned at the end of the TIPP treatment period, is
considered.
Measures
Socio-demographics and family characteristics were col-
lected at entry into the program, as was the past psy-
chiatric history of the patients.
Insight was assessed by judgment of the case man-
ager based on observation and conversation with the
respective patient (0, absence of insight; 1, partial in-
sight; 2, full insight). Full insight meant awareness of
the illness and the necessity of treatment. Partial in-
sight meant insight into the illness, but no awareness
of the consequences and the necessity of treatment.
Psychosocial functioning was assessed by the Social
and Occupational Functioning Assessment Scale
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(SOFAS; APA, 1994) ranging on a 1–100 scale, with 100
indicating a high level of functioning in a broad variety
of activities without physical and psychic alterations
in social, professional or academic relations and perfor-
mances, and by the Global Assessment of Functioning
Scale (GAF; Jones et al. 1995) ranging on a 1–100 scale,
with 100 indicating a high level of functioning in a
broad variety of activities going along with social func-
tioning, the ability to cope with problems and the
absence of symptoms. A self-rated construct of satisfac-
tion with life and self-esteem was assessed by the 26
items of the World Health Organization Quality Of
Life assessment scale (WHOQOL; The WHOQOL
Group, 1995) based on 5-point Likert scales ranging
from 1 (low satisfaction) to 5 (high satisfaction).
Medication adherence for the past 2 months was assessed
at each time point on a scale ranging from 1 (no adher-
ence, adherence <25% of the time) to 3 (full adherence,
adherence >75% of the time). A psychologist completed
the Positive and Negative Syndrome Scale for
Schizophrenia (PANSS; Kay et al. 1987) and the Brief
Psychiatric Rating Scale (BPRS; Overall & Gorham,
1962) for half of the patients. PANSS, BPRS, medication
adherence and WHOQOL were collected ﬁrst at the se-
cond time point of the study. Depressive symptoms were
assessed by averaging two items, one from the PANSS
(G6: Depression, including feelings of sadness, discour-
agement, helplessness, and pessimism) and one from
the BPRS (BPRS3: Depression, including sadness, un-
happiness, anhedonia and preoccupation with depres-
sing topics, hopelessness, loss of self-esteem), which
were highly correlated at each time point (0.91 < r < 0.95).
Statistical analysis
To test the ﬁrst hypotheses, a multilevel longitudinal
analysis was conducted in order to take into account
the variations at the time and individual levels. A
ﬁrst analysis was conducted, with time as level 1 and
individuals as level 2, to verify if insight exerted a
main effect and moderated the time effect on the evo-
lution of SOFAS and GAF. Similar analyses were rea-
lized on WHOQOL and depressive symptoms.
Analyses were conducted with MLwiN.2 software by
using the model of iterative generalized least squares
(Kreft & De Leeuw, 1998; Rasbah et al. 2009).
The last hypothesis about the causal effect of insight
on SOFAS and GAF at each time point was tested by
usingacross-laggedpanel analysiswithAMOSv.22 soft-
ware www-03.ibm.com/software/products/fr/spss-amos
and the LAVAAN procedure of R (www.r-project.org).
We began by comparing a fully reciprocal model with
a basic model without inﬂuence of both variables
(autoregressive model), and tested the ﬁt of the data of
the former two models when insight and respectively
SOFAS and GAFwere successively the source or the tar-
get of inﬂuence.
Preliminary analyses were conducted on missing
values to evaluate the inﬂuence of initial measures of
the main variables (insight, SOFAS, GAF) on the attri-
tion. Table 1 provides the breakdown of the partici-
pants included in the study at each time point for
each variable. The missing values increase from 4.6%
to 28.8% for insight, 5.4% to 26.7% for SOFAS and
8.8% to 26.7% for GAF. To check if the participants
lost during the study differ for the three measures, we
compared their scores when they entered the treatment
program with the scores of the remaining participants.
The comparisons revealed no statistically signiﬁcant dif-
ferences between the means of both groups on insight
(meanmiss = 0.98, S.D. = 0.70; meanrem = 0.79, S.D. = 0.71;
t227 = 1.90, p = 0.06), SOFAS (meanmiss = 39.64, S.D. =
16.01; meanrem = 37.65, S.D. = 15.84; t225 < 1) and GAF
(meanmiss = 37.05, S.D. = 15.10; meanrem = 34.59, S.D. =
15.67; t217 = 1.05, p = 0.30). Following these results, we
used the maximum likelihood method (available in
AMOS) to estimate the missing values for doing the
cross-lagged panel analyses. In the multilevel frame-
work all existing data were used in the estimation of
the models. Then, the multilevel analyses were only
conducted on the available observations.
Results
When entering the program, patients presented a
marked impairment of level of SOFAS (mean = 38.2,
S.D. = 15.9) and GAF (mean = 35.3, S.D. = 15.5). Insight
was positively correlated with SOFAS (r = 0.33, p <
0.001) and GAF (r = 0.35, p < 0.001). The latter two mea-
sures were highly correlated (r = 0.90, p < 0.001). Age
was slightly correlated with insight (r = 0.14, p =
0.041). There was no correlation between socio-
demographic characteristics (sex, level of education,
socio-professional origin, migration) and the three
measures (SOFAS, GAF, insight).
The improvement of SOFAS and GAF after treat-
ment initiation was followed by a collapse after 1
year, and a small improvement at the end of the obser-
vation (Table 1 and Fig. 1). There was a clear increase
in insight, whereas medication adherence appeared
to be more stable in time. The self-reported global self-
esteem and satisfaction with life (WHOQOL) was high
in comparison to the other measures and showed a
slight improvement. In addition, the depressive symp-
toms diminished over time. In order to validate our in-
sight measure for each time point of the study, we used
one item of the PANSS (G12: lack of judgment and
awareness), which has been used to validate insight
in previous studies (e.g. Buchy et al. 2010). The item
was highly correlated with insight at each time point
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(−0.56 < r <−0.40, p < 0.001). Insight was also corre-
lated, but in a less systematic way, with medication ad-
herence (0.25 < r < 0.56, p < 0.001). Depressive symptoms
were positively correlated with insight 2 months after
the beginning of the treatment (r = 0.21, p = 0.033), but
this positive association disappeared subsequently (r =
0.09 after 6 months and r =−0.03 after 3 years).
A schematic presentation of the results obtained by
the multilevel analyses can be found in Fig. 2. The
multilevel analysis on SOFAS and GAF scores revealed
that adding the main effect of insight and the inter-
action effect of insight and time (Table 2, models 2)
clearly improved the models taking into account only
the effects of time (models 1).
Both models conﬁrmed an important increase in
functioning in the beginning of the treatment and an
enhanced tendency of improvement in the end of the
time-frame of observation (Fig. 1). They also revealed
Table 1. Evolution of insight, medication adherence, SOFAS, GAF, WHOQOL and depressive symptoms during treatment
Time points
(month)
Insight
mean (S.D.), n
Medication
adherence
mean (S.D.), n
SOFAS
mean
(S.D.), n
GAF
mean
(S.D.), n
WHOQOL
mean (S.D.), n
Depressive
symptoms
mean (S.D.), n
0 0.84 (0.71) 229 – 38.21 (15.88) 227 35.26 (15.52) 219 – –
2 1.14 (0.68) 213 1.50 (0.76) 202 49.95 (15.62) 217 47.12 (16.33) 217 3.32 (0.60) 86 3.17 (1.62) 112
6 1.33 (0.64) 203 1.45 (0.77) 195 55.39 (14.65) 210 53.33 (15.15) 212 3.40 (0.55) 94 2.87 (1.45) 135
12 1.38 (0.66) 195 1.49 (0.76) 180 57.28 (15.37) 206 55.85 (15.77) 207 3.45 (0.61) 92 2.78 (1.36) 121
18 1.42 (0.64) 179 1.49 (0.81) 166 58.26 (15.04) 192 56.50 (15.30) 192 3.60 (0.60) 101 2.63 (1.46) 122
24 1.40 (0.66) 175 1.56 (0.77) 167 57.24 (15.86) 186 55.78 (16.35) 185 3.55 (0.58) 95 2.44 (1.32) 121
30 1.46 (0.64) 168 1.57 (0.76) 170 58.23 (15.17) 174 57.00 (16.17) 174 3.64 (0.61) 91 2.19 (1.25) 111
36 1.44 (0.64) 171 1.57 (0.76) 171 58.94 (15.95) 176 57.10 (17.05) 176 3.61 (0.54) 81 2.31 (1.29) 94
Scale 0–2 1–3 1–100 1–100 1–5 1–5
SOFAS, Social and Occupational Functioning Assessment Scale; GAF, Global Assessment of Functioning Scale; WHOQOL,
World Health Organization Quality Of Life assessment scale.
Fig. 1. Evolution of estimated and observed SOFAS scores according to level of insight during the treatment. Insight: obs,
SOFAS observed score; est, SOFAS estimated score (multilevel analysis).
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a slight decrease in functioning in the middle of the
process. The signiﬁcant random effect of insight at
the individual level shows that there are important in-
dividual differences, which depend in particular on the
level of initial psychosocial and functioning resources:
The increase in functioning was inversely associated
with the initial levels of SOFAS and GAF.
Thedepressive symptoms starting fromtimepoint two
were then added into the model as there were no mea-
sures for time point zero. The multilevel model did
hence not include time point zero, and the number of
valid observations diminished (n = 743). Nevertheless,
results conﬁrm the preceding observation except for the
disappearance of the signiﬁcant interaction between
insight and time due to the exclusion of the ﬁrst time
point. Depressive symptoms exerted a signiﬁcant princi-
pal and negative effect (SOFAS: β =−1.995, S.E. = 0.303,
p < 0.001; GAF: β =−2.327, S.E. = 0.319, p < 0.001), but did
not interact with time nor decreased ormoderated the ef-
fect of insight. Moreover, the principal effect of insight
completely suppressed the moderate positive effect of
medication adherence on both psychosocial and func-
tioning measures.
Multilevel analyses were then conducted on the de-
pressive symptoms and the WHOQOL, as a self-
reported measure of self-esteem and life satisfaction.
The results (Table 3) showan interaction effect of insight
and time on the depressive symptoms (model 2), which
suppressed themain effect of time (model 1).Depressive
symptoms decreasedmore in timewith a high degree of
insight. We observed a cumulative linear and quadratic
effect of time and an interaction effect of insight and time
on the WHOQOL. Patients evaluated their self-esteem
independently of their insight at the beginning of the
treatment, but the improvement in time of the
WHOQOL was then positively correlated to insight.
A schematic presentation of the results obtained by
the cross-lagged panel analysis can be found in
Fig. 2. Our last hypothesis concerned the causal
direction of the relations between insight and the two
Fig. 2. Schematic representation of the estimated relations between Insight, SOFAS, depressive symptoms and Self-esteem
obtained from the multilevel and cross-lagged panel analyses. Continuous lines indicate a positive coefﬁcient and dotted lines
indicate a negative coefﬁcient: *** p < 0.001; ** p < 0.01; * p < 0.05. Subscripts designate time points. H1, H2, H3 refer to the
hypotheses: H1, positive effect of insight on SOFAS would increase with time; H2, negative effect of insight on depressive
symptoms and positive effect of insight on self-esteem would increase with time; H3, insight at tx would have a positive
effect on SOFAS at tx+1.
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Table 2. Estimates and standard errors of the multilevel longitudinal modeling of the evolution of SOFAS and GAF with insight
SOFAS GAF
Model 0 Model 1 Model 2 Model 0 Model 1 Model 2
Fixed effects
Intercept 53.1328 (0.8149) 41.0592 (0.9599) 35.6630 (1.1896) 51.3587 (0.8281) 38.2530 (0.9899) 31.7478 (1.1894)
Level 2 (individuals)
Insight 6.3089 (0.8316) 7.4195 (0.8378)
Insight × time 0.1086 (0.0332) 0.0996 (0.0348)
Level 1 (time)
Time (linear) 2.9038 (0.1909) 2.1879 (0.1802) 3.0465 (0.2005) 2.2749 (0.1894)
Time (quadratic) −0.1460 (0.0134) −0.1186 (0.0126) −0.1495 (0.0141) −0.1195 (0.0132)
Time (cubic) 0.0022 (0.0003) 0.0018 (0.0002) 0.0022 (0.0003) 0.0018 (0.0002)
Random effects
Individual variance 129.1936 (14.4640) 134.3735 (14.1748) 143.9920 (23.076) 131.1189 (14.8826) 138.1630 (14.6487) 131.0208 (22.4000)
Insight slope variance 37.2646 (8.7981) 29.7610 (8.4465)
Insight × intercept covariance −38.6373 (12.4359) −29.4393 (11.9537)
Time variance 159.5469 (6.3370) 110.9210 (4.4073) 87.9493 (3.7163) 177.7199 (7.0431) 120.9925 (4.7789) 97.23 338 (4.1016)
Deviance 12316.04 11847.24 11605.59 12419.59 11926.98 11670.49
Observations 1504 1504 1504 1499 1499 1499
SOFAS, Social and Occupational Functioning Assessment Scale; GAF, Global Assessment of Functioning Scale.
All effects are statistically signiﬁcant at p < 0.001 (Wald χ21 test).
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Table 3. Estimates and standard errors of the multilevel longitudinal modeling of the evolution of the depressive symptoms and the WHOQOL from second to last measurement point with insight
Depressive symptoms WHOQOL
Model 0 Model 1 Model 2 Model 0 Model 1 Model 2
Fixed effects
Intercept 2.6388 (0.0765)*** 3.1037 (0.0978)*** 3.0020 (0.0955)*** 3.5049 (0.0406)*** 3.2765 (0.0571)*** 3.2822 (0.0589)***
Level 2 (individuals)
Insight – –
Insight × time −0.0132 (0.0020)*** 0.0056 (0.0017)***
Level 1 (time)
Time (linear) −0.0274 (0.0037)*** – 0.0224 (0.0055)*** 0.0150 (0.0059)**
Time (quadratic) – – −0.0004 (0.0001)** −0.0004 (0.0001)**
Random effects
Individual variance 0.8426 (0.1192) 0.8401 (0.1164) 0.9547 (0.1292) 0.2208 (0.0297) 0.2235 (0.0296) 0.2177 (0.0289)
Time variance 1.2075 (0.0689) 1.1160 (0.0637) 1.0436 (0.0626) 0.1391 (0.0093) 0.1285 (0.0086) 0.1267 (0.0084)
Deviance 2728.73 2674.46 2451.92 828.94 790.63 779.55
Observations 816 816 816 613 613 613
WHOQOL, World Health Organization Quality Of Life assessment scale.
*** p < 0.001; ** p < 0.01 (Wald χ21 test).
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measures of psychosocial functioning. The results
revealed that the cross-lagged SOFAS and insight
model ﬁtted the data better than the basic autoregres-
sive model, respectively (χ272 = 89.91, p = 0.084, CFI =
0.991, RMSEA = 0.032, 90% CI 0.000–0.051; χ286 =
144.24, p < 0.001, CFI = 0.969, RMSEA = 0.053, 90% CI
0.038–0.068; Δχ214 = 54.33, p < 0.001). The two models
predicting a unilateral effect (of insight on SOFAS or
the reverse) had worse ﬁt than the cross-lagged
model (both models: Δχ27 > 25.00, p < 0.01). The regres-
sion coefﬁcients indicated a more complex pattern of
relations between SOFAS and insight than the
expected one (Table 4).
There was a strong and positive mutual inﬂuence at
the beginning of the treatment. The level of SOFAS had
then a signiﬁcant negative effect on the consecutive
level of insight and a slightly negative inﬂuence in
the ﬁrst year after the early phase of psychosis and in
the end of the treatment. The effects of insight alter-
nated between positive and negative inﬂuences on
the consecutive level of SOFAS, even if the positive
effects were stronger. Finally, a more parsimonious
model including only the signiﬁcant paths (four of in-
sight on SOFAS and two in the other direction) did not
differ from the complete cross-lagged model (χ278 =
100.96, p = 0.041, CFI = 0.988; RMSEA = 0.035, 90% CI
0.008–0.053; Δχ26 = 11.05, p > 0.10).
The analysis conducted on the cross-lagged GAF
and insight model offered comparable results. First,
the cross-lagged model ﬁtted the data better than the
autoregressive one, respectively (χ272 = 86.14, p = 0.122,
CFI = 0.991; RMSEA = 0.029, 90% CI 0.000–0.049; χ286 =
130.44, p = 0.001, CFI = 0.992, RMSEA = 0.047, 90% CI
0.029–0.062; Δχ214 = 44.30, p < 0.001). Then, both unilat-
eral effects models signiﬁcantly differed from the
cross-lagged model, but the unilateral effect of insight
on GAF showed a worse ﬁt (Δχ27 = 24.32, p < 0.01) than
the reverse one (Δχ27 = 17.57, p < 0.05). As in the
preceding analysis, we observed a strong and positive
mutual inﬂuence in the beginning of the treatment, fol-
lowed by a signiﬁcant negative effect of GAF on the
consecutive insight. Then, no effect reached a statistical
signiﬁcant inﬂuence (Table 4). Yet, a parsimonious
model including only the three signiﬁcant effects
(two of GAF on insight and one in the reverse direc-
tion) was worse than the complete cross-lagged
model (χ283 = 106.34, p = 0.043, CFI = 0.987, RMSEA =
0.034, 90% CI 0.007–0.052; Δχ211 = 20.20, p < 0.05),
which suggests that one should rather consider the glo-
bal pattern.
These results showed a strong initial causal and re-
ciprocal inﬂuence, but then the paths indicated con-
trasting positive and negative effects of insight on
SOFAS and GAF, while in return SOFAS and GAF
tend to diminish the level of insight.
Discussion
The present study investigated the modulating effect of
insight in the early phase of psychosis on the evolution
of psychosocial functioning over 3 years. It ﬁlled exist-
ing research gaps by following patients thoroughly
over time within a social identity perspective. Our
results point to the importance of insight for the devel-
opment of psychosocial outcomes in the early course of
psychosis and complement a few previous ﬁndings
obtained with patients suffering from established
schizophrenia (van Baars et al. 2013). As expected,
they demonstrate an evolving positive relation of in-
sight over the initial phase of treatment for emerging
psychosis, which remains stable when controlling for
depressive symptoms. Furthermore, they also show a
positive effect of insight with time on a measure of self-
reported satisfaction with life and self-esteem and a
negative effect on depressive symptoms. Depressive
symptoms seem to be a drawback in the beginning
Table 4. Regression weights and standard errors of the cross-lagged models between insight and respectively SOFAS and GAF
Time points (t)
Regression weights (S.E.)
Insightt−1 SOFASt SOFASt−1 Insightt Insightt-1 GAFt GAFt-1 Insightt
2 4.133 (1.277)*** 0.006 (0.002)** 4.056 (1.257)*** 0.006 (0.003)*
6 −0.970 (1.555) −0.010 (0.004)** −0.176 (1.680) −0.009 (0.004)*
12 2.905 (1.211)* −0.002 (0.003) 2.243 (1.422) −0.004 (0.003)
18 −2.277 (1.303) −0.005 (0.003) −1.473 (1.430) −0.003 (0.003)
24 3.102 (1.359)* 0.003 (0.003) 2.043 (1.503) 0.004 (0.003)
30 −3.328 (1.540)* −0.006 (0.004) −2.958 (1.688) −0.006 (0.004)
36 2.118 (1.388) −0.003 (0.003) 0.520 (1.652) −0.003 (0.003)
SOFAS, Social and Occupational Functioning Assessment Scale; GAF, Global Assessment of Functioning Scale.
*** p < 0.001; ** p < 0.01; * p < 0.05.
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of the process, which is in line with previous studies
for shorter time-frames (Mintz et al. 2004; Saeedi et al.
2007). Our hypothesis of a positive causal impact of in-
sight on social functioning could not be systematically
conﬁrmed. The cross-lagged analysis revealed a strong
reciprocal inﬂuence between insight and the two mea-
sures of psychosocial functioning at the beginning of
the treatment, followed by a negative effect of psycho-
social functioning on insight in a second phase. After 1
year, there are only slight effects of insight,which alterna-
tively increase or decrease the functional outcomes. This
pattern of results points to amore complex interactionbe-
tween variations in adherence to an illness identity and
variations in the evolution of psychosocial functioning.
Even if our study did not directly assess identity
variables, the ﬁndings suggest that identity processes
intervene in the regulation of psychosocial functioning.
First, patients develop a more positive illness identity
during the treatment, as evidenced by the increasing
positive relation between insight and self-reports of
life satisfaction and self-esteem and the decreasing
negative relation between insight and depressive
symptoms during the process. Second, the positive re-
lation of insight and social and occupational function-
ing increased over time, and patients with full insight
follow a more stable recuperation curve after 1 year
than those with no insight. This evolution can easily
be articulated with the adherence to an illness identity
associated with the enhancement of self-esteem, which
favors in return the recuperation of psychosocial func-
tioning (Haslam et al. 2009). Third, considering insight
and identity processes as a socio-cognitive conﬂict of
identiﬁcation within the development of a new social
self-deﬁnition, the complexity of the interaction of the
causal links between insight and functioning outcomes
might reﬂect the actual conﬂict of identiﬁcation. This is
supported by the intrapersonal variability we ﬁnd in
insight over time. In the same way, the negative rela-
tionships of SOFAS and GAF on insight after the im-
portant functional improvement at the beginning of
the treatment can be explained when considering that
a fast gain in psychosocial resources could also lead
patients to revise their acknowledgment of the diagno-
sis and deny the endorsement of a schizophrenic iden-
tity. Hence, the bidirectional positive and negative
interactions could reﬂect the process in which psycho-
social functioning can either stress a lack of insight, or,
on the other hand, enforce the development of insight
(Williams, 2008). Then, the situation at treatment onset
shows an interdependencyof insight and identity-related
variables. In this context, itwouldbe interesting for future
studies to investigate more directly the identity process
by using speciﬁcmeasures of identiﬁcation and bydiffer-
entiating between aspects focusing on activities and
aspects focusing on relations in psychosocial functioning.
Some limitations of our study need to be mentioned.
First, insight, SOFAS and GAF were evaluated by the
same case managers who could have inferred the level
of insight from the level of the psychosocial functioning.
However, the probability of such a bias appears weak.
Case managers had to integrate information from third
parties in order to evaluate thework and family environ-
mentof thepatient anddid therefore not only relyon their
subjective perception. Furthermore, the level of insight is
validated by the correlations with a pertinent item of the
PANSS, which was rated by a psychologist, and the
results of the effects of insight on the self-rated
WHOQOL conﬁrm those obtained with SOFAS and
GAF. Second, insight was conceptualized as a holistic
measure in this study comprising the awareness of illness
aswell as the acceptance of treatmentwhile recent studies
suggest insight is multidimensional and should be
assessed as such (Tranulis et al. 2008; Capdevielle et al.
2013). This is due to the fact that the current study is
based ondata collected prospectively in the frame of a co-
hort study where the initial aim was not restricted to the
study of insight and its correlation with outcomes.
Besides, in the literature, a correlation between psycho-
social outcomes and insight was mainly found regarding
the self-reﬂection related cognitive component of insight
(Raffard et al.2013), adimensionwhichwedidnot include
in the current study. Given numerous conceptualizations
and measurements of insight (self-rated, observed or by
interview; one or several dimensions; see also Dam,
2006), future research should vary insight measures and
compare them to each other with regard to their interac-
tions with psychosocial functioning. Finally, our study
encountered a common limitation in clinical repeated
measures with high missing and attrition data rates. Yet,
a comparison between valid and missing patient data at
each timepoint revealednosigniﬁcantdifferences regard-
ing the measures we used in this study.
Conclusions
Our ﬁndings show the central role which insight plays
for the evolution of psychosocial functional outcomes
in the early phase of psychosis. Future studies should
include direct identity measures in order to disentan-
gle the complex interactions revealed by some results
of the study. This extends to treatment approaches spe-
ciﬁcally aiming at the improvement of insight, which
has proven moderate effects so far (Pijnenborg et al.
2013). During the treatment of early phase of psych-
osis, one should consider identity processes of the
patients and, if it is possible, accept that these take
time. An inclusion of the social identity perspective
could add signiﬁcant value to both research and treat-
ment perspectives in early course of psychosis and
schizophrenia.
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